Siemens Healthineers will rebrand its in vitro diagnostics business under the name Olyrian Diagnostics as it prepares the unit to operate as a standalone company.
The new name will be introduced in phases, and the separation is expected to be completed by mid-2028, according to a Nov. 5 news release from the company.
Siemens Healthineers also plans to shorten its name to Healthineers, with both changes moving forward simultaneously, the release said.
The diagnostics business, which produces more than 16 billion tests a year, will remain part of Siemens Healthineers until the separation is complete. The company said customers will see no immediate changes to products, services, contracts or points of contact.
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
